RYTHMODAN 250 mg A LIBERATION PROLONGEE, coated tablet 20 tablets
Active ingredients: Disopyramide, Disopyramide phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Coated tablet20 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RYTHMODAN 250 mg A LIBERATION PROLONGEE, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 20 comprimé(s)
- Marketing authorisation holder
- CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Apr 1983
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69235837CIP73246026CIP133400932460267Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DISOPYRAMIDE (PHOSPHATE DE)comprimé | 322,5 mg · un comprimé | SA |
| DISOPYRAMIDEcomprimé | 250 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.